· Periodic Report
Q3 operating profit KRW 15.5 billion, up 74.5% from a year earlier
Medytox sold KRW 59.3 billion in Q3 and made KRW 15.5 billion from its main business, up 74.5% from a year earlier and up 226.0% from the prior quarter.
Medy-Tox Inc. Disclosures
086900 · KOSDAQ · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from Medy-Tox Inc..